2009Practical Preventive MedicineRequires access

Method for Measuring Antiviral Susceptibility of Herpes Simplex Virus Type 1 and Establishment of Resistant Strain

Yu Qigui

Open publisher page 0 citations

Abstract

Objective To develop the method for measuring antiviral susceptibility and to establish an acyclovir-resistant herpes simplex virus type 1(HSV-1). Methods Baby hamster kidney cells were inoculated with HSV-1,and acyclovir(ACV) was added to the medium in various concentrations.After 72 hours' incubation,plaques were counted and the 50% inhibiting concentration(IC50) was calculated.HSV-1 was incubated in the presence of ACV for 9 passages.The IC50 of ACV was determined after the 3rd,6th and 9th passages. Results The IC50 of ACV to HSV-1 SM44 was 0.7 μg/ml.In the presence of ACV,emergence of drug resistance was observed after the 3rd passage;the IC50 of ACV after the 3rd,6th and 9th passages was 7.2 μg/ml,34.2 μg/ml,and 85.3 μg/ml,respectively. Conclusions Plaque reduction assay is an efficient method for determination of antiviral drug susceptibility of HSV and the establishment of ACV-resistant strain is essential for the study of resistance.

About this research paper

What this paper is about

Objective To develop the method for measuring antiviral susceptibility and to establish an acyclovir-resistant herpes simplex virus type 1(HSV-1). Methods Baby hamster kidney cells were inoculated with HSV-1,and acyclovir(ACV) was added to the medium in various concentrations.After 72 hours' incubation,plaques were counted and the 50% inhibiting concentration(IC50) was calculated.HSV-1 was incubated in the presence of ACV for 9 passages.The IC50 of ACV was determined after the 3rd,6th and 9th passages. Results The IC50 of ACV to HSV-1 SM44 was 0.7 μg/ml.In the presence of ACV,emergence of drug resistance was observed after the 3rd passage;the IC50 of ACV after the 3rd,6th and 9th passages was 7.2 μg/ml,34.2 μg/ml,and 85.3 μg/ml,respectively. Conclusions Plaque reduction assay is an efficient method for determination of antiviral drug susceptibility of HSV and the establishment of ACV-resistant strain is essential for the study of resistance.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To develop the method for measuring antiviral susceptibility and to establish an acyclovir-resistant herpes simplex virus type 1(HSV-1). Methods Baby hamster kidney cells were inoculated with HSV-1,and acyclovir(ACV) was added to the medium in various concentrations.After 72 hours' incubation,plaques were counted and the 50% inhibiting concentration(IC50) was calculated.HSV-1 was incubated in the presence of ACV for 9 passages.The IC50 of ACV was determined after the 3rd,6th and 9th passages. Results The IC50 of ACV to HSV-1 SM44 was 0.7 μg/ml.In the presence of ACV,emergence of drug resistance was observed after the 3rd passage;the IC50 of ACV after the 3rd,6th and 9th passages was 7.2 μg/ml,34.2 μg/ml,and 85.3 μg/ml,respectively. Conclusions Plaque reduction assay is an efficient method for determination of antiviral drug susceptibility of HSV and the establishment of ACV-resistant strain is essential for the study of resistance.

Key concepts: Herpes simplex virus, IC50, Virology, Baby hamster kidney cell, Virus, Drug resistance, Incubation, Hamster

Related papers

Back to paper searchBrowse research topicsOriginal source
Method for Measuring Antiviral Susceptibility of Herpes Simplex Virus Type 1 and Establishment of Resistant Strain — Research Paper | ScholarLens